CHYMF(CHYMF)
CHYMF
No analyst ratings available
No analyst price targets available for CHYMF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.23B | $1.54B | $1.54B |
| Low | $1.15B | $1.23B | $1.32B |
| High | $1.31B | $1.85B | $1.76B |
| EBITDA Avg | $436M | $546M | $545M |
| Low | $407M | $436M | $468M |
| High | $465M | $656M | $622M |
| EBIT Avg | $378M | $474M | $473M |
| Low | $354M | $378M | $406M |
| High | $403M | $570M | $540M |
| Net Income Avg | $120M | $156M | $178M |
| Low | $98M | $127M | $145M |
| High | $142M | $185M | $211M |
| EPS Avg | $0.11 | $0.14 | $0.17 |
| Low | $0.09 | $0.12 | $0.13 |
| High | $0.13 | $0.17 | $0.20 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |